Ardent Health Partners (NYSE:ARDT) Price Target Raised to $25.00

Ardent Health Partners (NYSE:ARDT) had its price objective lifted by Leerink Partners from $23.00 to $25.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have an outperform rating on the stock.

ARDT has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. Morgan Stanley assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued an “overweight” rating and a $27.00 price target on the stock. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Royal Bank of Canada assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued an “outperform” rating and a $23.00 price target on the stock. Finally, JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued a “neutral” rating and a $18.00 price target on the stock. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $21.82.

Ardent Health Partners Stock Down 6.9 %

Shares of ARDT stock opened at $16.59 on Tuesday. Ardent Health Partners has a 1 year low of $14.57 and a 1 year high of $20.72. The business’s fifty day moving average is $18.18. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Ardent Health Partners (NYSE:ARDT) last announced its earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.05. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, analysts anticipate that Ardent Health Partners will post 1.25 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health Partners

Institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the 3rd quarter valued at $42,000. Financial Management Professionals Inc. acquired a new stake in shares of Ardent Health Partners in the 3rd quarter valued at $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners during the 3rd quarter worth about $135,000. Quadrature Capital Ltd acquired a new position in Ardent Health Partners during the 3rd quarter worth about $229,000. Finally, Barclays PLC acquired a new position in Ardent Health Partners during the 3rd quarter worth about $385,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.